The pleiotropic effects of adaptogens in depression: A Systematic Review
DOI:
https://doi.org/10.12775/JEHS.2026.87.67771Keywords
adaptogens, depression, pleiotropic mechanisms, treatment, psychiatryAbstract
Depression is a condition that affects increasingly larger groups of people. It involves, among other things, disturbances in neurotransmitter function and nervous system metabolism. The reason for this condition is often an excessive amount of stimuli, according to which the brain must adapt the body to survive in changing conditions. The differences in age, race, gender, and social status that would typically identify groups at higher or lower risk of developing depression are becoming blurred. Today, depressive disorders pose a danger to the entire population. They affect people in various ways. They can result from pathological changes and processes in different systems of the body. Adaptogens, which have strong pleiotropic effects, can be used to improve the patient's condition, well-being, and clinical status across various disorders of the entire body. These are plant-based substances that do not have as well-developed a legislative process as typical drugs on the pharmacological market. However, they play a significant role in supporting the treatment of various organ diseases throughout the body. At the same time, they alleviate neurological aberrations in the course of depressive disorders. In addition, both their antidepressant and health-promoting effects on other systems are mutually beneficial. Therefore, the use of adaptogens can benefit patients and significantly improve their quality of life during illness.
References
Alhasani RH, Alsharif I, Albalawi AE, Albalawi FE, Mohammedsaleh ZM, Saleh FM, Barnawi J, Alshammari NS, Basoudan NS, Ghouth NM, Almohaimeed HM, Hasan T, Ellatif SA, Soliman MH. Anti-inflammatory and anti-diabetic role of Ashwagandha (Withania somnifera) in a type 2 diabetes mellitus mouse model: a study using histological, molecular, and pathological parameters. Protoplasma. 2025 Jul 28. doi: 10.1007/s00709-025-02096-4. Epub ahead of print. PMID: 40717151.
Anderson RJ, Freedland KE, Clouse RE, Lustman P. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001; 24(6): 1069-1078.
Anderson SE, Cohen P, Naumova EN, Jaques PF, Must A. Adolescent obesity and risk for subsequent major depressive disorder and anxiety disorder: prospective evidence. Psychosom Med. 2007;69:740–747. doi: 10.1097/PSY.0b013e31815580b4.
Andersson NW, Gustafsson LN, Okkels N, et al. Psychol Med. 2015;45(16):3559-3569.
Andersson NW, Gustafsson LN, Okkels N, et al. Depression and the risk of autoimmune disease: a nationally representative, prospective longitudinal study. Psychol Med. 2015;45:3559–69. doi: 10.1017/S0033291715001488.
Anwer T, Sharma M, Pillai KK, Iqbal M. Effect of Withania somnifera on insulin sensitivity in non-insulin-dependent diabetes mellitus rats. Basic Clin Pharmacol Toxicol. 2008 Jun;102(6):498-503. doi: 10.1111/j.1742-7843.2008.00223.x. Epub 2008 Mar 16. PMID: 18346053.
Balasubramani S.P., Venkatasubramanian P., Kukkupuni S.K., Patwardhan B. Plant-based Rasayana drugs from Ayurveda. Chin. J. Integr. Med. 2011;17(2):88–94. doi: 10.1007/s11655-011-0659-5.
Barrett NE, Holbrook L, Jones S, Kaiser WJ, Moraes LA, Rana R, Sage T, Stanley RG, Tucker KL, Wright B, et al. Future innovations in anti-platelet therapies. Br J Pharmacol 2008;154(5):918e39.
Bartra Alegría A.F.G.S., Felimón E., Carranza E., Felipe R. Autoconcepto y depresión Enel estudiantes universitarios de una universidad privada. Red. Rev. Cient. Am. Lat. Caribe España Port. 2016;6:53–68. doi: 10.17162/au.v6i2.116.
Bialek K, Czarny P, Strycharz J, et al. Major depressive disorders accompanying autoimmune diseases-Response to treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2019;95:109678. doi:10.1016/j.pnpbp.2019.109678.
Bobba-Alves N., Juster R.P., Picard M. The energetic cost of allostasis and allostatic load. Psychoneuroendocrinology. 2022;146:105951. doi: 10.1016/j.psyneuen.2022.105951.
Brigitta B. Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci. 2022; 4(1): 7–20. doi:10.31887/DCNS.2002.4.1/bbondy
Carney RM, Freedland KE, Veith RC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med. 2005;67:S29–33.
Chen X, Zeng M, Chen C, Zhu D, Chen L, Jiang Z. Efficacy of psycho-cardiology therapy in patients with acute myocardial infarction complicated with mild anxiety and depression. Front Cardiovasc Med. (2022) 9:1031255. 10.3389/fcvm.2022.1031255
Choi K, Chun J, Han K, et al. Risk of Anxiety and Depression in Patients with Inflammatory Bowel Disease: A Nationwide, Population-Based Study. J Clin Med. 2019;8:654. doi: 10.3390/jcm8050654.
Committee on Herbal Medicinal Products (2008). Reflection paper on the adaptogenic concept. London, 8 May 2008 Doc. Ref. EMEA/HMPC/102655/2007 http://www.emea.europa.eu
Cosgrove MP, Sargeant LA, Griffin SJ. Occup Med (Lond). 2008;58(1):7-14.
de Wit L, Luppino F, van Straten A, et al. Psychiatry Res. 2010;178(2):230-235.
Dickens C. Depression in people with coronary heart disease: prognostic significance and mechanisms. Curr Cardiol Rep. (2015) 17(10):83. 10.1007/s11886-015-0640-6
Dindo LN, Recober A, Haddad R, Calarge CA. Comorbidity of migraine, major depressive disorder, and generalized anxiety disorder in adolescents and young adults. Int. J. Behav. Med. 2017; 24(4): 528–534. Doi: 10.1007/s12529-016-9620-5.
Dresler T, Caratozzolo S, Guldolf K, Huhn JI, Loiacono C, Niiberg-Pikksööt T i wsp.; European Headache Federation School of Advanced Studies (EHF-SAS). Understanding the nature of psychiatric comorbidity in migraine: A systematic review focused on interactions and treatment implications. J. Headache Pain 2019; 20(1): 51. Doi: 10.1186/s10194-019-0988-x
Drosselmeyer J, Jacob L, Rathmann W, et al. Depression risk in patients with late-onset rheumatoid arthritis in Germany. Qual Life Res. 2017;26:437–43. doi: 10.1007/s11136-016-1387-2.
Du X, Pang TY. Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases? Front Psychiatry. 2015 Mar 9;6:32. doi: 10.3389/fpsyt.2015.00032. PMID: 25806005; PMCID: PMC4353372.
Endale M, Lee W, Kamruzzaman S, Kim S, Park J, Park M, Park TY, Park HJ, Cho JY, Rhee MH. Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phos- phorylation and MAPK activation. Br J Pharmacol 2012;167(1):109e27.
Fanelli G, Serretti A. Depression, antidepressants, and insulin resistance: which link? Eur Neuropsychopharmacol. 2022; 60: 4-6.
Fanelli G, Mota NR, Salas-Salvadó J, et al. The link between cognition and somatic conditions related to insulin resistance in the UK biobank study cohort: a systematic review. Neurosci Biobehav Rev. 2022; 143:104927.
Fasipe OJ. Moving from the old monoaminergic theory toward the emerging hypothesis in the rational design of rapid-onset novel antidepressants. Medical Journal of Dr DY Patil University. 2019; 12(4): 292-315.
Finnell JE, Wood SK. Neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stress. Neurobiol Stress. 2016 May 4;4:1-14. doi: 10.1016/j.ynstr.2016.04.001. PMID: 27981185; PMCID: PMC5146276.
Fioranelli M, Roccia MG, Przybylek B, Garo ML. The role of brain-derived neurotrophic factor (BDNF) in depression and cardiovascular disease: a systematic review. Life. 2023;13:1967.
Gatica H., Aliste M., Guerrero J., Goecke I.A. Effects of methotrexate on the expression of the translational isoforms of glucocorticoid receptors α and β: Correlation with methotrexate efficacy in rheumatoid arthritis patients. Rheumatology. 2011;50:1665–1671. doi: 10.1093/rheumatology/ker126.
Gerardo G, Peterson N, Goodpaster K, Heinberg L. Depression and Obesity. Curr Obes Rep. 2025 Jan 3;14(1):5. doi: 10.1007/s13679-024-00603-x. PMID: 39752052.
Gold SM, Köhler-Forsberg O, Moss-Morris R, et al. Comorbid depression in medical diseases. Nat Rev Dis Primers. 2020; 6(1): 69.
Hamer JA, Testani D, Mansur RB, Lee Y, Subramaniapillai M, McIntyre RS. Brain insulin resistance: a treatment target for cognitive impairment and anhedonia in depression. Exp Neurol. 2019; 315: 1-8.
Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35:1365–72.
Herrman H., Kieling C., McGorry P., Horton R., Sargent J., Patel V. Reducing the global burden of depression: A Lancet–World Psychiatric Association Commission. Lancet. 2019;393:e42–e43.doi: 10.1016/S0140-6736(18)32408-5.
Hodes GE, Pfau ML, Leboeuf M, et al. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc Natl Acad Sci U SA. 2014;111:16136–41. doi: 10.1073/pnas.1415191111.
Horwitz AV, Wakefield JC, Lorenzo-Luaces L. History of depression. The Oxford Handbook of Mood Disorders; Oxford Press; 2016: 11-23.
Hwang S-Y, Son DJ, Kim I-W, Kim D-M, Sohn S-H, Lee J-J, Kim SK. Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits. Phytother Res 2008;22(6):778e83.
Irfan M, Kim M, Rhee MH. Anti-platelet role of Korean ginseng and ginseno- sides in cardiovascular diseases. J Ginseng Res 2020;44(1):24e32.
Irfan M, Jeong D, Saba E, Kwon H-W, Shin J-H, Jeon B-R, Kim S, Kim SD, Lee DH, Nah SY, et al. Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling. Platelets 2019;30(5):589e 98.
Jaganjac M., Milkovic L., Zarkovic N., Zarkovic K. Oxidative stress and regeneration. Free Radic. Biol. Med.2022;181:154–165. doi: 10.1016/j.freeradbiomed.2022.02.004.
Kang SY, Schini-Kerth VB, Kim ND. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta. Life Sci 1995;56(19):1577e86.
Kim JA, Choi S, Choi D, Park SM. Pre-existing Depression among Newly Diagnosed Dyslipidemia Patients and Cardiovascular Disease Risk. Diabetes Metab J. 2020 Apr;44(2):307-315. doi: 10.4093/dmj.2019.0002. Epub 2019 Nov 1. PMID: 31701694; PMCID: PMC7188974.
Kim J-H. Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases. J Ginseng Res 2018;42(3):264e9.
Kim ND, Kang SY, Schini VB. Ginsenosides evoke endothelium-dependent vascular relaxation in rat aorta. Gen Pharmacol 1994;25(6):1071e7.
Kloiber S, Ising M, Reppermund S, et al. Overweight and obesity affect treatment response in major depression. Biol Psychiatry. 2007; 62(4): 321-326.
Kraus C, Kautzky A, Watzal V, et al. Body mass index and clinical outcomes in individuals with major depressive disorder: findings from the GSRD European multicenter database. J Affect Disord. 2023; 335: 349-357.
Lee CH, Kim J-H. A review on the medicinal potentials of ginseng and ginse- nosides on cardiovascular diseases. J Ginseng Res 2014;38(3):161e6.
Li C, Ford ES, Strine TW, Mokdad AH. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care. 2008; 31(1): 105-107. doi:10.2337/dc07-1154
Liu Q,He H,Yang J,Feng X,Zhao F,Lyu J.2020.Changes in the global burden of depression from 1990 to 2017: findings from the Global Burden of Disease study.J.Psychiatr.Res.126:134–40.
Luppino FS, de Wit LM, Bouvy PF, et al. Arch Gen Psychiatry. 2010;67(3):220-229.
Luppino FS, De Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, obesity, and depression. A systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67:220–229. doi: 10.1001/archgenpsychiatry.2010.2.
Mackman N. Triggers, targets and treatments for thrombosis. Nature 2008;451(7181):914e8.
Makhlouf EA, AlamElDeen YK, El-Shiekh RA, Okba MM. Unveilling the antidiabetic potential of ashwagandha (Withania somnifera L.) and its withanolides-a review. Nat Prod Res. 2024 Dec 13:1-16. doi: 10.1080/14786419.2024.2439009. Epub ahead of print. PMID: 39671378.
Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299–312. doi: 10.1016/S0140-6736(18)31948-2.
Mandlik Ingawale DS, Namdeo AG. Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects. J Diet Suppl. 2021;18(2):183-226. doi:10.1080/19390211.2020.1741484. Epub 2020 Apr 3. PMID: 32242751.
Melin EO, Thulesius HO, Hillman M, Svensson R, Landin-Olsson M, Thunander M. Lower HDL-cholesterol, a known marker of cardiovascular risk, was associated with depression in type 1 diabetes: a cross sectional study. Lipids Health Dis. 2019 Mar 18;18(1):65. doi: 10.1186/s12944-019-1009-4. PMID: 30885233; PMCID: PMC6421645.
Meng R, Yu C, Liu N, He M, Lv J, Guo Y, et al. Association of depression with all-cause and cardiovascular disease mortality among adults in China. JAMA Netw Open. 2020;3:e1921043.
Merikangas AK, Mendola P, Pastor PW, Reuben CA, Cleary SD. The association between major depressive disorder and obesity in US adolescents: results from the 2001-2004 National Health and Nutrition Examination Survey. J Behav Med. 2012;35:149–154. doi: 10.1007/s10865-011-9340-x.
Mirjalili M. H., Moyano E., Bonfill M., Cusido R. M., Palazón J. (2009). Steroidal lactones from withania somnifera, an ancient plant for novel medicine. Molecules 14 (7), 2373–2393.10.3390/MOLECULES14072373
Mikulska P, Malinowska M, Ignacyk M, Szustowski P, Nowak J, Pesta K, Szeląg M, Szklanny D, Judasz E, Kaczmarek G, Ejiohuo OP, Paczkowska-Walendowska M, Gościniak A, Cielecka-Piontek J. Ashwagandha (Withania somnifera)-Current Research on the Health-Promoting Activities: A Narrative Review. Pharmaceutics. 2023 Mar 24;15(4):1057. doi:10.3390/pharmaceutics15041057. PMID: 37111543; PMCID: PMC10147008.
Monroe SM, Harkness KL. 2011. Recurrence in major depression: a conceptual analysis. Psychol.Rev.118(4):655–74.
Ogłodek E, Szota A, Just M, Moś D, Araszkiewicz A. The role of the neuroendocrine and immunesystems in the pathogenesis of depression. Pharmacol Rep. 2014; 66: 776-781.
Panossian AG, Efferth T, Shikov AN, Pozharitskaya ON, Kuchta K, Mukherjee PK, Banerjee S, Heinrich M, Wu W, Guo DA, Wagner H. Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases. Med Res Rev. 2021 Jan;41(1):630-703. doi: 10.1002/med.21743. Epub 2020 Oct 25. PMID: 33103257; PMCID: PMC7756641.
Panossian A. G. (2013). Adaptogens in mental and behavioral disorders. Psychiatric Clin. N. Am.36 (1), 49–64. 10.1016/j.psc.2012.12.005
Panossian AG. Adaptogens in mental and behavioral disorders. Psychiatr Clin North Am. 2013 Mar;36(1):49-64. doi: 10.1016/j.psc.2012.12.005. PMID: 23538076.
Park J-S, Jang H-D, Hong J-Y, et al. Impact of ankylosing spondylitis on depression: a nationwide cohort study.Sci Rep. 2019;9:6736. doi: 10.1038/s41598-019-43155-0.
Patten SB, Williams JV, Lavorato DH, et al. Gen Hosp Psychiatry. 2008;30(5):407-413.
Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry. 2001;58:221–7.
Pomari E, Stefanon B, Colitti M. Effects of Two Different Rhodiola rosea Extracts on Primary Human Visceral Adipocytes. Molecules. 2015 May 11;20(5):8409-28. doi: 10.3390/molecules20058409. PMID: 25970041; PMCID: PMC6272273.
Pooja, Bawa A.S., Khanum F. Anti-inflammatory activity of Rhodiola rosea—“A second-generation adaptogen”.Phytother. Res. 2009;23:1099–10102. doi: 10.1002/ptr.2749.
Rajan S, McKee M, Rangarajan S, Bangdiwala S, Rosengren A, Gupta R, et al.Association of symptoms of depression with cardiovascular disease and mortality in low-, middle-, and high-income countries. JAMA Psychiatry. 2020;77:1052–63.
Rasool M., Varalakshmi P. Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro study. Vascul. Pharmacol. 2006;44:406–410. doi: 10.1016/j.vph.2006.01.015.
Saba E, Jeon BR, Jeong D-H, Lee K, Goo Y-K, Kim S-H, Sung CK, Roh SS, Kim SD, Kim HK, et al. Black ginseng extract ameliorates hypercholesterolemia in rats. J Ginseng Res 2016;40(2):160e8.
Schulz R, Beach SR, Ives DG, Martire LM, Ariyo AA, Kop WJ. Association between depression and mortality in older adults: the cardiovascular health study. Arch Intern Med. 2000;160:1761–8.
Sennesh E., Theriault J., Brooks D., van de Meent J.W., Barrett L.F., Quigley K.S. Interoception as modeling, allostasis as control. Biol. Psychol. 2022;167:108242. doi: 10.1016/j.biopsycho.2021.108242.
Shorey S, Ng ED, Wong CH. Global prevalence of depression and elevated depressive symptoms among adolescents: a systematic review and meta-analysis. Br J Clin Psychol. 2022; 61(2): 287-305.
Sikandan A., Shinomiya T., Nagahara Y. Ashwagandha root extract exerts anti- inflammatory effects in HaCaT cells by inhibiting the MAPK/NF-κB pathways and by regulating cytokines. Int. J. Mol. Med. 2018;42:425–434. doi: 10.3892/ijmm.2018.3608.
Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, et al. 2000. Multiple recurrences of major de-pressive disorder.Am.J.Psychiatry157:229–33
Sterling P. Allostasis: A model of predictive regulation. Physiol. Behav. 2012;106:5–15. doi:10.1016/j.physbeh.2011.06.004.
Supornsilpchai W, Sanguanrangsirikul S, Maneesri S, Srikiatkhachorn A. Serotonin depletion, cortical spreading depression, and trigeminal nociception. Headache 2006; 46(1): 34–39. Doi:10.1111/j.1526-4610.2006.00310.x.
Todorova V., Ivanov K., Delattre C., Nalbantova V., Karcheva-Bahchevanska D., Ivanova S.(2021). Plant adaptogens—History and future perspectives. Nutrients 13 (8), 2861.10.3390/nu13082861
Tousoulis D, Kampoli A-M, Tentolouris Nikolaos Papageorgiou C, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 2012;10(1):4e18.
Woroń J., Siwek M. (2018). Unwanted effects of psychotropic drug interactions with medicinal products and diet supplements containing plant extracts. Psychiatr. Pol. 52 (6), 983–996.10.12740/PP/OnlineFirst/80998
Yamamoto M, Uemura T, Nakama S, Uemiya M, Kumagai A. Serum HDL- cholesterol-increasing and fatty liver-improving actions of Panax ginseng in high cholesterol diet-fed rats with clinical effect on hyperlipidemia in man. Am J Chin Med 1983;11(1e4):96e101.
Zambrano J, Celano CM, Januzzi JL, Massey CN, Chung WJ, Millstein RA, et al.Psychiatric and psychological interventions for depression in patients with heart disease: a scoping review. J Am Heart Assoc. (2020) 9(22):e018686.10.1161/jaha.120.018686
Zhu X, Ren T, Xiong Q, Lin Z, Lin X, Lin G. Salidroside alleviates diet-induced obesity and insulin resistance by activating Nrf2/ARE pathway and enhancing the thermogenesis of adipose tissues. Food Sci Nutr. 2023 Jun 6;11(8):4735-4744. doi: 10.1002/fsn3.3450. PMID: 37576042; PMCID: PMC10420790.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Maciej Krężel, Olga Krężel, Marcelina Rybińska, Artur Szafraniec

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 2
Number of citations: 0